Ossenkoppele, Rik http://orcid.org/0000-0003-1584-7477
Leuzy, Antoine
Cho, Hanna
Sudre, Carole H.
Strandberg, Olof
Smith, Ruben
Palmqvist, Sebastian
Mattsson-Carlgren, Niklas
Olsson, Tomas
Jögi, Jonas
Stormrud, Erik
Ryu, Young Hoon
Choi, Jae Yong
Boxer, Adam L.
Gorno-Tempini, Maria L.
Miller, Bruce L.
Soleimani-Meigooni, David
Iaccarino, Leonardo
La Joie, Renaud
Borroni, Edilio
Klein, Gregory
Pontecorvo, Michael J.
Devous, Michael D. Sr
Villeneuve, Sylvia
Lyoo, Chul Hyoung
Rabinovici, Gil D.
Hansson, Oskar
,
,
Funding for this research was provided by:
Vrije Universiteit Amsterdam
Article History
Received: 24 September 2020
Accepted: 27 October 2020
First Online: 19 November 2020
Compliance with ethical standards
: Written informed consent was obtained from all participants, and local institutional review boards for human research approved the study. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: OH has acquired research support (for the institution) from Roche, Pfizer, GE Healthcare, Biogen, Eli Lilly, and AVID Radiopharmaceuticals. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen and Roche.GDR receives research support from NIH, Alz Assoc, American College of Radiology, Avid Radiopharmaceuticals, GE Healthcare, Life Molecular Imaging. In the past 2 years he has received consulting fees from Axon Neurosciences, Eisai, GE Healthcare, Johnson & Johnson, and Merck. He is an Associate Editor for JAMA Neurology.ALB receives research support from NIH (R01AG038791, U19AG063911), the Tau Research Consortium, the Association for Frontotemporal Degeneration, and the Bluefield Project to Cure Frontotemporal Dementia. He has served as a consultant for AGTC, Alector, Arkuda, Arvinas, Bioage, Ionis, Lundbeck, Passage BIO, Samumed, Ono, Sangamo, Stealth, Third Rock, Transposon, UCB, and Wave, and received research support from Avid, Eisai, Biogen, and Roche.MJP and MDD are employees of Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, and are minor stockholders in Eli Lilly.EB and GK are employees of F. Hoffmann-La Roche Ltd.The other authors report no conflict of interest.
: Code will be provided upon reasonable request.